Cochlear Company Description

Cochlear Limited provides implantable hearing solutions for children and adults worldwide.

The company offers cochlear implant systems, sound processor upgrades, bone conduction systems, and other products.

It also provides cochlear nucleus systems, including Nucleus sound processors, smart bimodal hearing solution, and Nucleus implants; cochlear Baha systems comprising Baha 6 max sound processor and Baha implant; and accessories, such as wireless devices and Nucleus water-safe accessories.

The company was founded in 1981 and is headquartered in Sydney, Australia.

Cochlear Limited

Country	Australia
Founded	1981
Industry	Medical Devices
Sector	Healthcare
Employees	5,500
CEO	Diggory Howitt

Contact Details

Address: 1 University Avenue Sydney, NSW 2109 Australia
Phone	61 2 9428 6555
Website	cochlear.com

Stock Details

Ticker Symbol	COH
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU000000COH5
SIC Code	3842

Key Executives

Name	Position
Diggory William Howitt BE (Hons), MBA	Chief Executive Officer, MD, President and Executive Director
Dr. Sarah Thom	Chief Financial Officer
Jan Janssen MSc Elec Eng	Chief Technology Officer
Stuart Sayers	President of Asia Pacific and Latin America
Karen O'Driscoll	Chief Information Officer
Rob McGrory	Group General Counsel and Company Secretary
Jennifer Stevenson	Vice President of Corporate Communications and Brand
Dean Phizacklea	Senior Vice President of Global Strategic Marketing
Jennifer Hornery	Senior Vice President of Global People and Culture
Greg Bodkin BE (Hons), MComm (UNSW)	Senior Vice President of Global Supply Chain